KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Cme (CME) Invested Capital (2016 - 2025)

Historic Invested Capital for Cme (CME) over the last 17 years, with Q3 2025 value amounting to $28.2 billion.

  • Cme's Invested Capital fell 267.76% to $28.2 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $28.2 billion, marking a year-over-year decrease of 267.76%. This contributed to the annual value of $27.2 billion for FY2024, which is 186.55% up from last year.
  • According to the latest figures from Q3 2025, Cme's Invested Capital is $28.2 billion, which was down 267.76% from $27.7 billion recorded in Q2 2025.
  • Over the past 5 years, Cme's Invested Capital peaked at $29.0 billion during Q3 2024, and registered a low of $26.6 billion during Q1 2021.
  • For the 5-year period, Cme's Invested Capital averaged around $27.7 billion, with its median value being $27.8 billion (2023).
  • In the last 5 years, Cme's Invested Capital soared by 694.84% in 2021 and then plummeted by 445.49% in 2022.
  • Quarter analysis of 5 years shows Cme's Invested Capital stood at $28.1 billion in 2021, then dropped by 4.45% to $26.9 billion in 2022, then fell by 0.58% to $26.7 billion in 2023, then increased by 1.87% to $27.2 billion in 2024, then increased by 3.5% to $28.2 billion in 2025.
  • Its Invested Capital stands at $28.2 billion for Q3 2025, versus $27.7 billion for Q2 2025 and $27.0 billion for Q1 2025.